Huhtinen Heikki, Varpe Pirita, Karvonen Jukka, Rantala Arto, Grönroos Juha M
Turku University Hospital, Division of Digestive Surgery and Urology , Turku , Finland.
Minim Invasive Ther Allied Technol. 2013 Dec;22(6):352-8. doi: 10.3109/13645706.2013.797911. Epub 2013 Jun 12.
Self-expanding metal stents (SEMSs) are increasingly used for the palliative treatment of incurable obstructing colorectal cancer. The aim of the current study was to evaluate clinical outcome, including technical and clinical success of stenting, and to identify factors associated with late complications of SEMS in palliation of incurable obstructing colorectal cancer.
Between 2003 and 2010 details of 56 patients who underwent an attempt of SEMS insertion for obstructive incurable colorectal cancer at Turku University Hospital were recorded to our database prospectively and analyzed retrospectively.
Technical success was achieved in 42 patients (75%) and clinical success in 39 patients (70%). Late complications related to SEMS occurred in 13 patients (31%). Ten patients (24%) needed re-intervention because of a complication: Eight ostomies, one Hartmann´s procedure due to late perforation and one re-stenting because of stent migration. Three patients with stent-related complications were treated conservatively. Chemotherapy and prolonged survival were risk factors for SEMS-related late complications and re-intervention.
SEMS insertion is a feasible procedure for the palliative treatment of obstructing colorectal cancer in patients with severe comorbidities and short life expectancy. However, for patients who are candidates for chemotherapy and have a longer life expectancy, other treatment options such as palliative tumor resection should also be considered.
自膨式金属支架(SEMS)越来越多地用于无法治愈的梗阻性结直肠癌的姑息治疗。本研究的目的是评估临床结果,包括支架置入的技术和临床成功率,并确定在无法治愈的梗阻性结直肠癌姑息治疗中与SEMS晚期并发症相关的因素。
2003年至2010年期间,图尔库大学医院对56例因无法治愈的梗阻性结直肠癌而尝试置入SEMS的患者的详细情况进行了前瞻性记录,并进行了回顾性分析。
42例患者(75%)技术成功,39例患者(70%)临床成功。13例患者(31%)发生了与SEMS相关的晚期并发症。10例患者(24%)因并发症需要再次干预:8例行造口术,1例因晚期穿孔行哈特曼手术,1例因支架移位行再次支架置入。3例有支架相关并发症的患者接受了保守治疗。化疗和生存期延长是与SEMS相关的晚期并发症和再次干预的危险因素。
对于合并症严重、预期寿命短的梗阻性结直肠癌患者,SEMS置入是一种可行的姑息治疗方法。然而,对于适合化疗且预期寿命较长的患者,也应考虑其他治疗选择,如姑息性肿瘤切除术。